BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prostate
,
Amniocentesis
,
Bleomycin
,
rs4950928
,
IL1A
,
cell-cell adhesion
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ERCC6L;jsessionid=D6EAC76887F7BDC68A826C0A09C7DB56
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Hematopoietic stem cell of bone marrow
Granulocyte-macrophage progenitor cell of bone marrow
T Lymphocyte (regulatory) of peripheral blood
Basophil of peripheral blood
Endometrium
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Anal penetration by penis
Microbial culture finding
Severe acute respiratory syndrome
Viral disease
Viral infections of the central nervous system
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Cholesterol, HDL
Anti-Retroviral Agents
Antigens, Polyomavirus Transforming
salubrinal
PTC-209
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
OTUD1
TOP2B
XIAP
ANGPT2
GNAS
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
RAD52 and ERCC6L/PICH have a compensatory relationship for genome stability in mitosis.
ERCC6L facilitates the progression of laryngeal squamous cell carcinoma by the binding of FOXM1 and …
PICH Activates Cyclin A1 Transcription to Drive S-Phase Progression and Chemoresistance in Gastric C…
ERCC6L facilitates the onset of mammary neoplasia and promotes the high malignance of breast cancer …
FIRRM/C1orf112 is synthetic lethal with PICH and mediates RAD51 dynamics.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for ERCC6L;jsessionid=D6EAC76887F7BDC68A826C0A09C7DB56
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ